Fulcrum Therapeutics, Inc.
$3.87
-0.02 (-0.51%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +4.3%
- 3 Months
- +23.2%
- YTD
- -65.8%
- 1 Year
- -40.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 97.5%
- Largest decline max drawdown, since Aug 2025
- -78.5%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.01
Own FULC?
See how FULC contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.